Collin Blakely MD, PhD

Dr. Collin Blakely is a medical oncologist specializing in the treatment of lung cancer. In addition to treating patients, he conducts research focusing on understanding the cellular and molecular mechanisms underlying lung cancer resistance to targeted therapies. His goal is to translate laboratory findings into new treatments for lung cancer patients.

Blakely received his bachelor's degree in molecular and cellular biology from the University of Washington. He attended the Medical Scientist Training Program at the University of Pennsylvania's Perelman School of Medicine, where he received his M.D. and Ph.D. degrees. He completed his fellowship training in medical oncology at UCSF.